The Beauty Health Company (NASDAQ:SKIN) Shares Sold by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. cut its stake in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 24.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,889,700 shares of the company's stock after selling 609,952 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 1.52% of Beauty Health worth $3,005,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new stake in Beauty Health in the fourth quarter valued at approximately $25,000. SG Americas Securities LLC lifted its stake in Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company's stock valued at $56,000 after acquiring an additional 9,749 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Beauty Health in the 4th quarter valued at $57,000. Renaissance Technologies LLC acquired a new stake in shares of Beauty Health in the fourth quarter worth $64,000. Finally, Newman Dignan & Sheerar Inc. raised its holdings in shares of Beauty Health by 39.1% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company's stock worth $113,000 after purchasing an additional 20,000 shares during the last quarter. 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Stock Performance

Shares of NASDAQ SKIN traded down $0.02 during midday trading on Wednesday, reaching $1.68. 96,709 shares of the stock were exchanged, compared to its average volume of 1,056,611. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The firm has a market cap of $209.79 million, a price-to-earnings ratio of -3.96 and a beta of 0.88. The firm has a 50-day simple moving average of $1.22 and a two-hundred day simple moving average of $1.45. The Beauty Health Company has a twelve month low of $0.78 and a twelve month high of $2.76.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.05. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The company had revenue of $69.60 million for the quarter, compared to analyst estimates of $63.88 million. As a group, analysts anticipate that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lowered their price target on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a report on Monday, May 5th.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.